MEREDITH JAMESON: Open Payments
NPI 1801546338 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 14 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $86 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| SANOFI-AVENTIS U.S. LLC | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Cleerly, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| bioMerieux Inc | 1 | $22 |
Products named: SAPIEN 3 Ultra RESILIA, FANAPT, TZIELD, CAPLYTA, Cleerly Ischemia, Cologuard Collection Kit, ZENPEP, BREZTRI.
Industry payments across CO — which companies pay providers there.
